bosentan anhydrous has been researched along with Vascular Malformations in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Deng, X; Li, W; Peng, Y; Wang, Y; Xiao, Y; Xiao, Z; Zeng, Y | 1 |
| Beghetti, M; Broberg, CS; Budts, W; D'Alto, M; Diller, GP; Dimopoulos, K; Gatzoulis, MA; Giannakoulas, G; Gu, H; Opotowsky, AR; Swan, L; Veldtman, G | 1 |
2 other study(ies) available for bosentan anhydrous and Vascular Malformations
| Article | Year |
|---|---|
Ligation of patent ductus venosus in a child with pulmonary arterial hypertension and hypersplenism: A case report.
Topics: Aftercare; Antihypertensive Agents; Bosentan; Cardiomegaly; Child, Preschool; Combined Modality Therapy; Echocardiography; Humans; Hypersplenism; Ligation; Male; Portal Vein; Pulmonary Arterial Hypertension; Radiography, Thoracic; Tadalafil; Tomography, X-Ray Computed; Treatment Outcome; Vascular Malformations; Vascular Resistance; Vasodilator Agents | 2020 |
Definition and Management of Segmental Pulmonary Hypertension.
Topics: Bosentan; Cardiac Surgical Procedures; Disease Management; Endothelin Receptor Antagonists; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Vascular Malformations | 2018 |